Exelixis, Inc. (NASDAQ:EXEL), a biopharmaceutical company with a market capitalization of $9.4 billion focused on developing and commercializing novel therapies for cancer treatment, stands at a ...

Corporation, a biopharmaceutical company specializing in the discovery, development, and commercialization of proprietary therapeutics, finds itself at a critical juncture as it navigates the ...

More than 100 projects have received support as part of the 2024 European Research Council (ERC) proof of concept competition ...

Imagine you’re a landowner with dozens or hundreds of mature hardwood trees — not a stretch, since the majority of forestland in the U.S. is privately owned. If you want to know the trees’ value, you’ ...

Monday's tech sector meltdown, triggered by DeepSeek's AI breakthrough, caused collateral damage to share prices in the ...

REGINA — Saskatchewan Pulse Growers is close to signing a new crop breeding agreement with the University of Saskatchewan’s ...

Interest in deep tech to jumpstart innovation has fueled the sector. How can corporates and startups leverage its potential?

Zenas BioPharma, Inc.’s ZBIO share price has surged by 13.37%, which has investors questioning if this is right time to sell.

Nuclear laboratories in Canada have shown interest in exploring the commercialization of small reactor designs. A Request for ...

Struggling with grief this Valentine’s Day? Discover practical tips to navigate the triggers, honor your emotions, and find ...

With the establishment of the Texas Space Commission in 2024 through House Bill 3447 and rapid innovations toward space commercialization ...

Learn more about whether ACADIA Pharmaceuticals Inc. or Legend Biotech Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.